Patent US4273878A successfully refreshed from Google Patents.
Patent US3998790A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3998790A Expired / Lapsed US ⏱️ 0.0 years remaining

Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases

Assignee: Hassle AB
•
Filing: 1974-01-15
•
Granted: 1976-12-21
•
Expires: 1994-01-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Para-substituted phenoxy-hydroxypropylamines having the general formula ##STR1## and pharmaceutically acceptable, non-toxic acid addition salts thereof, wherein R' is an isopropyl or tertiarybutyl radical; Z is a member selected from the group consisting of -OR", -SR", and -NHCOOR", R" being a straight or branched lower alkyl radical having 1 to 3 carbon atoms; and n is 1, 2, or 3, are disclosed as are methods for their preparation. Pharmaceutical preparations are prepared whose active ingredients include at least one of the newly discovered phenoxy-hydroxypropylamine compounds. Therapeutically effective doses of these preparations selectively block the β-receptors of the heart making them useful in treating heart diseases in animals including humans.

Inventors

  • 👤 Arne Elof Brandstrom
  • 👤 Per Arvid Emil Carlsson
  • 👤 Stig Ake Ingemar Carlsson
  • 👤 Hans Rudolf Corrodi
  • 👤 Lars Ek
  • 👤 Bengt Arne Hjalmar Ablad

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 21:37
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K31/138; A61K31/21; A61K31/27; A61P; A61P25/00; A61P25/02; A61P9/00; C; C07; C07C; C07C217/00; C07C217/02; C07C217/04; C07C217/28; C07C217/30; C07C217/32; C07C233/00; C07C233/01; C07C233/16; C07C233/17; C07C233/22; C07C317/00; C07C317/02; C07C317/10; C07C59/00; C07C59/40; C07C59/58; C07C59/64; C07C59/66; C07C59/68; C07D; C07D263/00; C07D263/02; C07D263/08; C07D263/16; C07D263/18; C07D263/20; C07D263/24; C07D303/00; C07D303/02; C07D303/12; C07D303/18; C07D303/20; C07D303/24; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 57 words
A compound of the formula ##STR21## and pharmaceutically acceptable, non-toxic acid addition salts thereof, wherein R' is an isopropyl or tertiary butyl radical; Z is a member selected from the group consisting of -OR", and -SR", R" being a straight or branched alkyl radical having 1 to 3 carbon atoms; and n is 1, 2, or 3.
Claim 2
Dependent Claim 57 words
A compound of the formula ##STR21## and pharmaceutically acceptable, non-toxic acid addition salts thereof, wherein R' is an isopropyl or tertiary butyl radical; Z is a member selected from the group consisting of -OR", and -SR", R" being a straight or branched alkyl radical having 1 to 3 carbon atoms; and n is 1, 2, or 3.
Claim 3
Dependent Claim 17 words
A compound according to claim 1 in racemic form and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 4
Dependent Claim 21 words
A compound according to claim 1 resolved into its optically active, levo-rotatory isomers and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 5
Dependent Claim 21 words
A compound according to claim 1 resolved into its optically active, dextro-rotatory isomer and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 6
Dependent Claim 10 words
A compound according to claim 1 wherein R' is isopropyl.
Claim 7
Dependent Claim 10 words
A compound according to claim 1 wherein Z is -OR".
Claim 8
Dependent Claim 10 words
A compound according to claim 1 wherein Z is -SR".
Claim 9
Dependent Claim 12 words
A compound according to claim 5 wherein Z is -OR" or -SR".
Claim 10
Dependent Claim 14 words
The compound of claim 1 (±)-1-isopropylamino-3-[p-(β-methoxyethylphenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 11
Dependent Claim 14 words
The compound of claim 1 (-)-1-isopropylamino-3-[p-(β-methoxyethylphenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 12
Dependent Claim 14 words
The compound of claim 1 (+0-1-isopropylamino-3-[p-(β-methoxyethylphenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 13
Dependent Claim 14 words
The compound of claim 1 (±)-1-isopropylamino-3-[p-(β-ethoxyethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 14
Dependent Claim 14 words
The compound of claim 1 (-)-1-isopropylamino-3-[p-(β-ethoxyethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 15
Dependent Claim 14 words
The compound of claim 1 (+)-1-isopropylamino-3-[p-(β-ethoxyethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 16
Dependent Claim 14 words
The compound of claim 1 (±)-1-isopropylamino-3-[p-(ethoxymethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 17
Dependent Claim 14 words
The compound of claim 1 (-)-1-isopropylamino-3-[p-(ethoxymethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 18
Dependent Claim 14 words
The compound of claim 1 (+)-1-isopropylamino-3-[p-ethoxymethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 19
Dependent Claim 9 words
The compound of claim 1 wherein R' is tert.-butyl.
Claim 20
Dependent Claim 14 words
The compound of claim 1 (±)-1-isopropylamino-3-[p-(β-methylmercaptoethyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.
Claim 21
Dependent Claim 14 words
The compoud of claim 1 (±)-1-isopropylamino-3-[p-(γ-methoxypropyl)-phenoxy]-propanol-2 and pharmaceutically acceptable, non-toxic acid addition salts thereof.

References Cited (Backward Citations)

US3203992A Cited
US3631108A Cited
US3541130A Cited
US3755413A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-12-21 1980-06-21 1980-12-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-12-21 1984-06-21 1984-12-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-12-21 1988-06-21 1988-12-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag